Heart Test Laboratories Inc. (HSCS) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
550 RESERVE ST, SUITE 360 SOUTHLAKE, TX 76092 |
| State of Incorp. | TX |
| Fiscal Year End | April 30 |
| Industry (SIC) | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 7/31/2024 MRQ | 4/30/2024 | 1/31/2024 MRQ | 4/30/2023 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 5,808 | 7,076 | 1,660 | |||
| Cash and cash equivalents | 5,808 | 7,076 | 1,660 | |||
| Receivables | 15 | |||||
| Inventory, net of allowances, customer advances and progress billings | 629 | 670 | 676 | |||
| Inventory | 629 | 670 | 676 | |||
| Prepaid expense | 184 | 233 | 143 | |||
| Deferred costs | 693 | 656 | 176 | |||
| Other current assets | 40 | 40 | 40 | |||
| Total current assets: | 7,354 | 8,691 | 2,697 | |||
| Noncurrent Assets | ||||||
| Operating lease, right-of-use asset | 462 | 483 | 529 | |||
| Property, plant and equipment | 98 | 58 | 61 | |||
| Intangible assets, net (including goodwill) | 1,589 | 1,569 | ||||
| Intangible assets, net (excluding goodwill) | 1,589 | 1,569 | ||||
| Total noncurrent assets: | 2,149 | 2,110 | 591 | |||
| TOTAL ASSETS: | 9,503 | 10,801 | 3,287 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 847 | 1,000 | 1,255 | |||
| Accounts payable | 448 | 415 | 631 | |||
| Accrued liabilities | 398 | 584 | 623 | |||
| Debt | 500 | 500 | 500 | |||
| Other liabilities | 34 | 108 | 49 | |||
| Other undisclosed current liabilities | 371 | 98 | 30 | |||
| Total current liabilities: | 1,752 | 1,706 | 1,833 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 500 | |||||
| Long-term debt, excluding current maturities | 500 | |||||
| Liabilities, other than long-term debt | 434 | 461 | 724 | |||
| Accounts payable and accrued liabilities | 187 | |||||
| Operating lease, liability | 434 | 461 | 536 | |||
| Total noncurrent liabilities: | 434 | 461 | 1,224 | |||
| Total liabilities: | 2,186 | 2,167 | 3,057 | |||
| Equity | ||||||
| Equity, attributable to parent, including: | 7,317 | 8,634 | 231 | |||
| Preferred stock | 0 | |||||
| Common stock | 1 | 64 | 10 | |||
| Additional paid in capital | 74,679 | 74,086 | 60,977 | |||
| Accumulated deficit | (67,362) | (65,516) | (60,757) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | ||||
| Total equity: | 7,317 | 8,634 | 231 | |||
| TOTAL LIABILITIES AND EQUITY: | 9,503 | 10,801 | 3,287 | |||
Income Statement (P&L) ($ in thousands)
| 7/31/2024 TTM | 4/30/2024 | 1/31/2024 TTM | 4/30/2023 | ||
|---|---|---|---|---|---|
| Revenues | 19 | 19 | 5 | ||
| Cost of revenue | (6) | (6) | (3) | ||
| Gross profit: | 13 | 13 | 2 | ||
| Operating expenses | (6,318) | (6,037) | (6,115) | ||
| Operating loss: | (6,306) | (6,025) | (6,113) | ||
| Nonoperating expense | (299) | (367) | (241) | ||
| Other nonoperating income | 55 | 0 | 2 | ||
| Interest and debt expense | (354) | (367) | (243) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | |||||
| Net loss: | (6,959) | (6,759) | (6,597) | ||
| Other undisclosed net income (loss) attributable to parent | 354 | 367 | 243 | ||
| Net loss available to common stockholders, diluted: | (6,605) | (6,391) | (6,354) | ||
Comprehensive Income ($ in thousands)
| 7/31/2024 TTM | 4/30/2024 | 1/31/2024 TTM | 4/30/2023 | ||
|---|---|---|---|---|---|
| Net loss: | (6,959) | (6,759) | (6,597) | ||
| Comprehensive loss, net of tax, attributable to parent: | (6,959) | (6,759) | (6,597) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.